1. Home
  2. PCB vs EOLS Comparison

PCB vs EOLS Comparison

Compare PCB & EOLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PCB Bancorp

PCB

PCB Bancorp

N/A

Current Price

$21.93

Market Cap

313.0M

Sector

Finance

ML Signal

N/A

Logo Evolus Inc.

EOLS

Evolus Inc.

N/A

Current Price

$5.26

Market Cap

304.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
PCB
EOLS
Founded
2003
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
313.0M
304.0M
IPO Year
2018
2018

Fundamental Metrics

Financial Performance
Metric
PCB
EOLS
Price
$21.93
$5.26
Analyst Decision
Hold
Strong Buy
Analyst Count
2
5
Target Price
$24.50
$15.50
AVG Volume (30 Days)
19.1K
1.4M
Earning Date
01-01-0001
05-21-2026
Dividend Yield
4.00%
N/A
EPS Growth
N/A
1.23
EPS
1.94
N/A
Revenue
$2,774,000.00
$297,176,000.00
Revenue This Year
$13.73
$14.41
Revenue Next Year
$9.07
$16.96
P/E Ratio
$11.35
N/A
Revenue Growth
4.68
11.61
52 Week Low
$16.02
$4.09
52 Week High
$24.20
$13.66

Technical Indicators

Market Signals
Indicator
PCB
EOLS
Relative Strength Index (RSI) 40.79 57.85
Support Level $21.12 $4.74
Resistance Level $22.30 $7.29
Average True Range (ATR) 0.70 0.31
MACD -0.13 0.17
Stochastic Oscillator 32.56 53.26

Price Performance

Historical Comparison
PCB
EOLS

About PCB PCB Bancorp

PCB Bancorp is a bank holding company, which engages in the provision of consumer and commercial banking services. It provides Personal, Business, and Loan services, which provide banking, lending, and digital, tools, home loans, and others. Also, it offers a broad range of loans, deposits, and other products and services predominantly to small and middle-market businesses and individuals. The company provided it's services in Los Angeles and Orange Counties, California; Bellevue, Washington; and Atlanta, Georgia.

About EOLS Evolus Inc.

Evolus Inc is a performance beauty company with a customer-centric approach to delivering breakthrough products in the self-pay aesthetic market. The company's first commercial product is Jeuveau, a proprietary 900 kilodalton, purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe glabellar lines, also known as frown lines, in adults. Its primary market is the cash-pay aesthetic market, which includes medical products purchased by physicians and other customers that are then sold to consumers or used in procedures for aesthetic indications. It generates product revenue from the sale of Jeuveau in the United States and Europe, and service revenue from distribution partners in Canada.

Share on Social Networks: